Occidental Petroleum (OXY)

Berkshire Hathaway is about to see the biggest change in its business in decades, but you shouldn't let that stop you from buying it.

Occidental Petroleum (OXY) is selling its OxyChem segment to Berkshire Hathaway for $9.7 billion, following its strategy to reduce debt.

In a financial landscape often dominated by growth narratives and tech giants, legendary investor Warren Buffett, through Berkshire Hathaway, continues to champion his time-tested value investing principles. As of late 2025, the "Oracle of Omaha" has once again turned heads with a series of significant investments in companies he and

Warren Buffett's $9.7B purchase is a bet whether OxyChem's moat can withstand Chinese cost structures. Investors should monitor US PVC margins from Chinese exports.

The long-standing, strategic relationship between Occidental Petroleum (NYSE: OXY) and Warren Buffett's Berkshire Hathaway (NYSE: BRK.A, BRK.B) has entered a new and pivotal phase, with Berkshire Hathaway agreeing to acquire Occidental's chemical division, OxyChem, for $9.7 billion in an all-cash transaction. Announced on October 2, 2025, and

These three MLPs have strong potential upside ahead.

Buffett's likely last deal is a win-win for the company.

Occidental Petroleum (NYSE: OXY) is a prominent international energy company currently undergoing a significant strategic transformation, with its recent activities and future direction heavily in focus as of October 2, 2025. Headquartered in Houston, Texas, Occidental is primarily engaged in the acquisition, exploration, and development of oil and gas properties across the United States, including [...]

Riyadh, Saudi Arabia – October 10, 2025 – The highly anticipated Innovation Zero MENA Congress, a premier platform dedicated to accelerating the Middle East and North Africa (MENA) region's net-zero transition, has been strategically rescheduled to October 2026 in Riyadh, Saudi Arabia. This pivotal decision, moving the event from its originally planned

The U.S. stock market is currently experiencing a fascinating dichotomy, with major indices persistently flirting with record highs even as the price of crude oil continues a notable descent. As of October 10, 2025, market sentiment is a complex blend of robust performance in key sectors, particularly technology, and

Berkshire Hathaway just agreed to a roughly $10 billion investment, setting up the new CEO for success.

Oxy turns to a familiar investor to raise cash and improve its balance sheet.

The unsung hero to the Oracle of Omaha's long-term investing outperformance is dividend stocks.

In a little less than 10 years, OpenAI has gone from an idea to a half-trillion-dollar company, and its ambitions for the next several years are much, much bigger. Plus, Fair Isaac Corporation is opening a new front in the battle for your credit score, and Berkshire Hathaway puts its massive cash pile to use.

Berkshire's OxyChem acquisition could be Buffett's last deal before he passes the torch to Greg Abel in a few months.

This year's weakness is rooted in misunderstanding and some misguided thinking.

Buffett's 60-year-plus investing track record is hard to beat.

Berkshire agreed to buy OxyChem for $9.7 billion while EA goes private for $55 billion. Also, Middleby seeks a $800 million deal.

Berkshire Hathaway has split the positions of chairman and CEO, setting Greg Abel up to succeed Warren Buffett as CEO starting in 2026.

Occidental Petroleum is making a transformational transaction.

Wall Street closed slightly higher as Tesla stumbled, crypto stocks soared, and AI excitement made its comeback, all while Washington remains paralyzed by a government shutdown.

The U.S. stock market finished higher on Thursday, as the Dow Jones Industrial Average edged up nearly 0.2% to 46,519.72.